In this study, Amlodipine has been used to study its effects in newly diagnosed hypertensive patients.
The incidence of hypertension is on the rise in developing countries like Pakistan. Different medications are used to decrease blood pressure with Amlodipine as one of the first-line drugs. It was proposed that due to interaction with calcium and thus luminal cholecystokinin releasing factor; Amlodipine might increase the cholesterol level and thus cause dyslipidemia. Objective: In this regard, this study was conducted to look into the effects of Amlodipine in newly diagnosed cases of hypertension that had received no medication previously. Methodology: Experimental study with a healthy control group with the sample size calculated out to be 80, comprising of an equal number of enrolment into case and control groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
80
5mg/day in two divided doses
Measurement of Blood Glucose Concentration
Measured as per protocols provided by the kit manufacturer.
Time frame: Four Months
Measurement of Total Plasma Cholesterol Concentration
Measured as per protocols provided by the kit manufacturer.
Time frame: Four Months
Measurement of Plasma Triglyceride Concentration
Measured as per protocols provided by the kit manufacturer.
Time frame: Four Months
Measurement of Plasma High Density Lipoproteins Concentration
Measured as per protocols provided by the kit manufacturer.
Time frame: Four Months
Measurement of Plasma Low Density Lipoproteins Concentration
Measured as per protocols provided by the kit manufacturer.
Time frame: Four Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.